Avedro, Inc.

Equities

AVDR

US05355N1090

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+0.61%	-.--%

2019	Avedro, Inc.(NasdaqGM:AVDR) dropped from S&P TMI Index	CI
2019	Avedro, Inc. Announces Board Changes	CI

Avedro, Inc. Announces CE Mark Clearance for Mosaic Advanced Cross-Linking System

December 23, 2015

Avedro, Inc. announced that it has received CE Mark clearance for its Mosaic System. The Mosaic System has the potential for non-surgical improvement for low myopia with a procedure called PiXL™ (Photorefractive Intrastromal Cross-linking). The Mosaic system is now commercially available outside of the United States.

Latest news about Avedro, Inc.

Avedro, Inc.(NasdaqGM:AVDR) dropped from S&P TMI Index	22/11/19	CI
Avedro, Inc. Announces Board Changes	21/11/19	CI
Avedro, Inc.(NasdaqGM:AVDR) dropped from NASDAQ Composite Index	21/11/19	CI
Glaukos Corporation completed the acquisition of Avedro, Inc. from a group of sellers.	20/11/19	CI
Avedro, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	06/11/19	CI
Certain Common Stock of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	12/08/19	CI
Certain Options of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	12/08/19	CI
Certain Warrants of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	12/08/19	CI
Certain Restricted Stock Units of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.	12/08/19	CI
Avedro, Inc. Announces Resignation of Thomas W. Burns and Gilbert H. Kliman from the Board of Directors	07/08/19	CI
Avedro, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2019; Revises Revenue Guidance for the Full Year of Fiscal 2019	07/08/19	CI
Glaukos Corporation entered into a definitive merger agreement to acquire Avedro, Inc. from a group of sellers for approximately $490 million.	06/08/19	CI
Avedro, Inc.(NasdaqGM:AVDR) added to Russell 2000 Dynamic Index	28/06/19	CI
Avedro, Inc.(NasdaqGM:AVDR) added to S&P TMI Index	24/06/19	CI
Transcript : Avedro, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 05:15 PM	15/05/19
Transcript : Avedro, Inc., Q1 2019 Earnings Call, May 09, 2019	09/05/19
Avedro, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2019; Revises Revenue Guidance for the Full Year of Fiscal 2019	09/05/19	CI
Transcript : Avedro, Inc., Q4 2018 Earnings Call, Mar 21, 2019	21/03/19
Avedro, Inc. Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2018; Provides Revenue Guidance for the Full Year of 2019	21/03/19	CI
Avedro, Inc.(NasdaqGM:AVDR) added to NASDAQ Composite Index	15/02/19	CI
Avedro, Inc. has completed an IPO in the amount of $70 million.	13/02/19	CI
Avedro, Inc. has filed an IPO in the amount of $86.25 million.	18/01/19	CI
Avedro To Seek Acquisition	18/01/19	CI
Avedro, Inc. Auditor Raises 'Going Concern' Doubt	20/12/18	CI
Avedro, Inc. Announces That Permanent J Code Issued for Avedro’S Photrexa® Drug Formulations	20/11/18	CI

Chart Avedro, Inc.

Duration

Period

More charts

Company Profile

Avedro Inc is a United States-based company. The Company is an ophthalmic pharmaceutical and medical device company developing and commercializing a suite of products based on its corneal collagen cross-linking technology platform to address a wide variety of ophthalmic disorders and conditions, primarily associated with corneal weakness. Its primary components of the Avedro Cross-Linking Platform are pharmaceutical formulations of riboflavin (vitamin B2), a âsingle dose pharmaceutical,â sold primarily in conjunction with the Companyâs innovative devices for the delivery of metered doses of ultraviolet (UVA) light, a medical device.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AVEDRO, INC.	-.--%	403M
ABBOTT LABORATORIES	-6.45%	180B
MEDTRONIC PLC	-6.92%	98.89B
BECTON, DICKINSON AND COMPANY	-6.46%	66.26B
DEXCOM, INC.	-9.97%	44.61B
CENCORA, INC.	+7.43%	44.02B
HOYA CORPORATION	+10.13%	40.12B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.13%	29.19B
WEST PHARMACEUTICAL SERVICES, INC.	-7.87%	23.64B
TERUMO CORPORATION	+13.33%	23.41B

Other Medical Equipment, Supplies & Distribution